| アブストラクト | Mepolizumab is primarily used in the treatment of asthma, eosinophilic granulomatosis with polyangiitis, eosinophilia syndrome, and chronic rhinitis with nasal polyps. The information about its adverse drug reactions is mainly derived from clinical trials, and there is a shortage of real-world studies with extensive sample sizes. In this study, the U.S. FDA's Adverse Event Reporting System (FAERS) database was analyzed to evaluate the side effects of mepolizumab. A total of 18,040 reports of mepolizumab-associated adverse events were identified from the FDA Adverse Event Reporting System database. Multiple disproportionality analysis algorithms were used to determine the significance of these AEs. The study identified 198 instances of mepolizumab-induced AEs, including some important AEs not mentioned in the product labeling. The time to onset of adverse reactions was also analyzed, with a median time of 109 days. Most AEs occurred within the first month of mepolizumab use, but some may still occur after 1 year of treatment. Gender-specific analysis showed different high-risk AEs for females (digestive and neurological side effects) and males (serious adverse effects leading to hospitalization and death). The findings mentioned provide valuable insights on optimizing the use of mepolizumab, enhancing its effectiveness, and minimizing potential side effects. This information will greatly contribute to the practical implementation of the drug in clinical settings. |
|---|
| ジャーナル名 | Frontiers in pharmacology |
|---|
| 投稿日 | 2024/1/8 |
|---|
| 投稿者 | Zou, Fan; Zhu, Chengyu; Lou, Siyu; Cui, Zhiwei; Wang, Dan; Ou, Yingyong; Wang, Li; Chen, Junyou; Lan, Yuanbo |
|---|
| 組織名 | Department of Respiratory and Critical Care Medicine, Affiliated Hospital of;Zunyi Medical University, Zunyi, China.;Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an;Jiaotong University, Xi'an, China.;Department of Respiratory and Critical Care Medicine, The Second Affiliated;Hospital of Xi'an Jiaotong University, Xi'an, China. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38186645/ |
|---|
